Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
64 studies found for:    Open Studies | "Warfarin"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Warfarin"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
Condition: Indications for Warfarin Therapy
Intervention: Drug: Warfarin Sodium
2 Recruiting Pradaxa or Warfarin for Prevention of Recurrent DVT in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy
Conditions: Dabigatran Etexilate;   Recurrence of DVT;   Pulmonary Embolism;   Warfarin
Interventions: Drug: Dabigatran Etexilate;   Drug: Warfarin;   Procedure: angiography, tensiometry of pulmonary artery, catheter thrombus fragmentation;   Drug: Pradaxa;   Device: PigTail catheter
3 Recruiting Assessing the Ability of Warfarin Treated Patients to Predict Their INR
Condition: Atrial Fibrillation
Intervention:
4 Recruiting Pharmacogenomics of Warfarin in Hispanics and Latinos
Conditions: Thrombosis;   Hemorrhage
Interventions: Procedure: Cheek Swab/ Mouthwash sample;   Procedure: Blood Draw
5 Recruiting Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers
Condition: Atrial Fibrillation
Intervention:
6 Recruiting Use of Warfarin After the First Trimester in Pregnant Women With APS
Conditions: Recurrent Miscarriage;   Antiphospholipid Syndrome
Interventions: Drug: Enoxaparin;   Drug: Warfarin
7 Recruiting The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.
Conditions: Heart Valve Disease;   Older Than 18-years-old;   Without Any Liver or Kidney Diseases
Intervention: Genetic: CYP2C9;VKORC1
8 Recruiting Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin
Condition: Hypoprothrombinemia
Interventions: Other: Warfarin adjustment using the Fearon algorithm;   Other: Warfarin adjustment using standard dosing
9 Not yet recruiting The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin
Condition: Blood Coagulation Disorders
Intervention: Drug: Voltaren ophtha 0.1%
10 Not yet recruiting Assessment of 2012 Bioequivalence Standards for Warfarin
Condition: Healthy
Intervention: Drug: warfarin
11 Recruiting Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
Condition: Atrial Fibrillation
Interventions: Drug: apixaban;   Drug: warfarin
12 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Genetic: Pharmacogenetic;   Drug: Target INR 1.8
13 Recruiting A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Coagulopathies;   Pulmonary Embolism
Interventions: Genetic: Genotype-guided;   Other: Standard-of-Care
14 Recruiting Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity
Conditions: Atrial Fibrillation;   Thrombus Due to Heart Valve Prosthesis
Intervention: Drug: Warfarin
15 Recruiting Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
Conditions: Cirrhosis;   Hypertension;   Venous Thrombosis;   Status; Splenectomy
Interventions: Drug: Warfarin;   Drug: Dipyridamole;   Drug: Aspirin;   Drug: Low Molecular Weight Heparin
16 Recruiting Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
Conditions: Cirrhosis;   Hypertension;   Status;Splenectomy;   Venous Thrombosis
Interventions: Drug: Warfarin;   Drug: Dipyridamole;   Drug: Aspirin;   Drug: Low Molecular Weight Heparin
17 Recruiting Excessive Warfarin Anticoagulation - Causes and Consequences
Condition: Anticoagulation
Intervention:
18 Recruiting Comparison Between Thoracoscopic Left Atrial Appendage Excision and Warfarin for the Secondary Prevention of Stroke in Patients With AF
Conditions: Atrial Fibrillation;   Stroke;   Systemic Embolism
Interventions: Procedure: Thoracoscopic Left Atrial Appendage Excision;   Drug: Warfarin
19 Recruiting Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Conditions: Cancer;   Venous Thromboembolism;   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Blood Clot
Interventions: Drug: Rivaroxaban;   Drug: Apixaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: Warfarin;   Drug: Dalteparin;   Drug: Enoxaparin;   Drug: Fondaparinux
20 Recruiting Genotype-guided Warfarin Individualized Treatment
Conditions: Atrial Fibrillation;   Deep Venous Thrombosis
Interventions: Behavioral: Genotype-guided dosing algorithm for warfarin;   Behavioral: Standard initiation dose for warfarin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.